• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤溶酶和胰蛋白酶诱导的高分子量激肽原的一些分子和功能变化。

Some molecular and functional changes in high molecular weight kininogen induced by plasmin and trypsin.

作者信息

Kleniewski J, Donaldson V H, Wagner C J

出版信息

Thromb Res. 1982 Mar 1;25(5):387-99. doi: 10.1016/0049-3848(82)90129-3.

DOI:10.1016/0049-3848(82)90129-3
PMID:6176044
Abstract

When purified human HMW-kininogen was digested by plasmin, its specific antigenic properties were initially enhanced and then gradually destroyed, but its clot-promoting activity (Fitzgerald factor activity) was only slightly decreased. When endogenous serum plasminogen was activated by streptokinase, similar alterations in specific HMW-kininogen antigens and Fitzgerald factor activity occurred. In contrast, trypsin induced increased antigenic properties initially, but readily destroyed the Fitzgerald factor activity and less readily destroyed the specific HMW-kininogen antigenic properties in purified HMW-kininogen and in normal human serum. When normal serum was treated with streptokinase, the antigenic properties shared by HMW and LMW-kininogens were in Sephadex G-200 fractions of lower molecular weight than in the case of untreated serum, but the elution volumes of specific HMW-kininogen antigens and Fitzgerald factor activity were not significantly altered. When prekallikrein-deficient serum was subjected to the same G-200 gel filtration process, there was a broad overlap in the elution volumes of antigens shared by both HMW and LMW-kininogens with specific HMW-kininogen antigenic and coagulant properties, which remained after streptokinase treatment of the serum. Depsite the disparate rates of destruction of the antigenic and clot-promoting portion of HMW-kininogen by proteases these properties did not separate from one another during ion exchange chromatography.

摘要

当纯化的人高分子量激肽原被纤溶酶消化时,其特异性抗原特性最初增强,然后逐渐被破坏,但其促凝活性(菲茨杰拉德因子活性)仅略有下降。当内源性血清纤溶酶原被链激酶激活时,高分子量激肽原特异性抗原和菲茨杰拉德因子活性也会发生类似变化。相比之下,胰蛋白酶最初会使抗原特性增加,但会迅速破坏菲茨杰拉德因子活性,并且在纯化的高分子量激肽原和正常人血清中较不容易破坏高分子量激肽原的特异性抗原特性。当用链激酶处理正常血清时,高分子量和低分子量激肽原共有的抗原特性在葡聚糖凝胶G-200分离组分中的分子量比未处理血清的情况更低,但高分子量激肽原特异性抗原和菲茨杰拉德因子活性的洗脱体积没有明显改变。当将前激肽释放酶缺乏的血清进行相同的葡聚糖凝胶G-200凝胶过滤过程时,高分子量和低分子量激肽原共有的抗原与高分子量激肽原特异性抗原和凝血特性在洗脱体积上有广泛重叠,这些特性在血清经链激酶处理后仍然存在。尽管蛋白酶对高分子量激肽原的抗原和促凝部分的破坏速率不同,但在离子交换色谱过程中这些特性并未彼此分离。

相似文献

1
Some molecular and functional changes in high molecular weight kininogen induced by plasmin and trypsin.纤溶酶和胰蛋白酶诱导的高分子量激肽原的一些分子和功能变化。
Thromb Res. 1982 Mar 1;25(5):387-99. doi: 10.1016/0049-3848(82)90129-3.
2
Plasma high molecular weight kininogen concentration in health and in chosen impairments of haemostasis. Evidence that plasmin uncovers a new antigenic site in high molecular weight kininogen.健康状态及特定止血功能受损情况下的血浆高分子量激肽原浓度。纤溶酶揭示高分子量激肽原新抗原位点的证据。
Thromb Haemost. 1979 Oct 31;42(3):1046-55.
3
Function and immunochemistry of prekallikrein-high molecular weight kininogen complex in plasma.血浆中前激肽释放酶-高分子量激肽原复合物的功能与免疫化学
J Clin Invest. 1980 Feb;65(2):413-21. doi: 10.1172/JCI109684.
4
Purification of high molecular weight kininogen and the role of this agent in blood coagulation.高分子量激肽原的纯化及其在血液凝固中的作用。
J Clin Invest. 1977 Sep;60(3):584-94. doi: 10.1172/JCI108810.
5
Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.人高分子量激肽原的裂解显著增强其凝血活性。该分子作为前辅因子存在的证据。
J Clin Invest. 1984 Apr;73(4):954-62. doi: 10.1172/JCI111319.
6
Radioimmunoassay of human high molecular weight kininogen in normal and deficient plasmas.正常血浆和缺乏血浆中人类高分子量激肽原的放射免疫测定
J Lab Clin Med. 1980 Apr;95(4):563-74.
7
Comparison of human high molecular weight kininogen digestion by plasma kallikrein and by plasmin. A revised method of purification of high molecular weight kininogen.血浆激肽释放酶和纤溶酶对人高分子量激肽原消化作用的比较。一种改进的高分子量激肽原纯化方法。
J Lab Clin Med. 1987 Apr;109(4):469-79.
8
The role of bovine high-molecular-weight (HMW) kininogen in contact-mediated activation of bovine factor XII: interaction of HMW kininogen with kaolin and plasma prekallikrein.牛高分子量(HMW)激肽原在接触介导的牛因子XII激活中的作用:HMW激肽原与高岭土和血浆前激肽释放酶的相互作用。
J Biochem. 1981 Jun;89(6):1699-709. doi: 10.1093/oxfordjournals.jbchem.a133370.
9
Characterization of human high molecular weight kininogen. Procoagulant activity associated with the light chain of kinin-free high molecular weight kininogen.人高分子量激肽原的特性。与无激肽高分子量激肽原轻链相关的促凝血活性。
J Exp Med. 1978 Feb 1;147(2):488-99. doi: 10.1084/jem.147.2.488.
10
Plasmin induced changes in high molecular weight kininogen (HMW-K).纤溶酶诱导的高分子量激肽原(HMW-K)变化。
Adv Exp Med Biol. 1983;156:165-73.